Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Ellora Trading
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Vaxfab Enterprise

WEBSITE BSE:542803 NSE: VEL Inc. Year: 1983 Industry: Trading My Bucket: Add Stock

₹50 0.5 | 0.9%

Last updated: 11:28

Consolidated Standalone

Last updated: 11:28

My Notes

No Notes Added Yet

Vaxfab Enterprise Overview

Ellora Trading Ltd deals in insulators and related allied product in India. Its products include strain insulators, pin, suspension. It also engages in the buying and selling of textile clothes. The company was established in 1983 and is based in Ahmedabad, India.

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Vaxfab Enterprise Key Financials

Market Cap ₹118 Cr.

Stock P/E 201.3

P/B 2.7

Current Price ₹50

Book Value ₹ 18.3

Face Value 10

52W High ₹56

Dividend Yield 0%

52W Low ₹ 12.9

Edit Ratio

Vaxfab Enterprise Share Price

₹ | |

Volume
Price

Vaxfab Enterprise Quarterly Price

Quarterly Monthly
Show Value Show %

Vaxfab Enterprise Peer Comparison

Vaxfab Enterprise Quarterly Results

#(Fig in Cr.) Sep 2022 Dec 2022 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 0 2 2 2 1 0 11 3 15 55
Other Income 0 0 0 -0 0 1 -0 0 -1 -3
Total Income 0 2 2 2 1 1 11 3 14 52
Total Expenditure 0 2 2 6 1 0 19 1 13 54
Operating Profit -0 0 0 -4 -0 1 -8 2 1 -3
Interest -0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 -4 -0 1 -8 2 1 -3
Provision for Tax -0 0 0 0 -1 0 0 0 0 -0
Profit After Tax 0 0 0 -4 1 1 -8 2 0 -2
Adjustments -0 -0 -0 0 0 0 0 -0 -0 0
Profit After Adjustments 0 0 0 -4 1 1 -8 2 0 -2
Adjusted Earnings Per Share 0 0.4 0.1 -5.3 0.7 0.7 -9.8 2.1 0.5 -2.7

Vaxfab Enterprise Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 0 1 2 1 0 0 1 0 17 9 59 84
Other Income 0 0 0 0 0 0 0 0 0 0 1 -4
Total Income 0 1 2 1 0 0 1 0 17 9 60 80
Total Expenditure 0 1 2 1 0 0 1 0 16 13 59 87
Operating Profit 0 0 0 0 0 -0 -0 0 0 -4 1 -8
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 0 -0 -0 0 0 -4 1 -8
Provision for Tax 0 -0 0 0 0 0 0 0 0 -1 0 0
Profit After Tax 0 0 0 0 0 -0 -0 0 0 -4 1 -8
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 0 -0 -0 0 0 -4 1 -8
Adjusted Earnings Per Share 0.4 0 0.1 0.1 0.1 -0.1 -0.1 0 0.4 -4.2 0.7 -9.9

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 556% 0% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 285% 45% 16% NA%
ROE Average 5% -6% -3% 1%
ROCE Average 4% -6% -4% 1%

Vaxfab Enterprise Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 0 3 3 3 3 3 3 3 16 13 13
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 -1 -1
Total Current Liabilities 0 0 1 0 0 0 0 0 10 5 99
Total Liabilities 1 3 4 3 3 3 3 3 27 18 112
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0 2 1 1 2 3 1 1 12 8 6
Total Current Assets 1 2 3 2 1 1 2 2 14 9 106
Total Assets 1 3 4 3 3 3 3 3 27 18 112

Vaxfab Enterprise Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 4 0
Cash Flow from Operating Activities 0 -1 -0 0 1 0 -1 -0 2 -7 -6
Cash Flow from Investing Activities 0 -1 1 -0 0 -1 1 0 -12 4 -2
Cash Flow from Financing Activities 0 2 -0 0 -1 0 0 0 14 -0 8
Net Cash Inflow / Outflow 0 -0 -0 -0 0 -0 -0 0 4 -4 -0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 4 0 0

Vaxfab Enterprise Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.43 0.04 0.06 0.09 0.15 -0.05 -0.05 0.01 0.4 -4.25 0.7
CEPS(Rs) 0.54 0.04 0.06 0.13 0.19 -0.01 -0.01 0.05 0.41 -4.19 0.74
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 1.93 11.68 11.74 11.83 11.97 11.92 11.87 11.88 19.24 14.99 15.68
Core EBITDA Margin(%) 0 0.61 -0.44 3.24 1.36 -61.23 -6.12 -32.32 2.76 -46.75 -0.3
EBIT Margin(%) 0 1.05 1.06 2.66 14.43 -11.62 -1.08 1.32 2.71 -45.74 1.22
Pre Tax Margin(%) 0 0.96 1.05 2.65 14.41 -11.63 -1.09 1.21 2.69 -45.74 1.2
PAT Margin (%) 0 1.08 0.7 1.79 10.52 -11.84 -1.09 0.92 2 -39.04 1
Cash Profit Margin (%) 0 1.08 0.7 2.51 13.14 -3.19 -0.31 4.18 2.05 -38.5 1.05
ROA(%) 20.01 0.52 0.4 0.61 1.06 -0.36 -0.37 0.08 2.25 -16.17 0.9
ROE(%) 25.45 0.63 0.5 0.77 1.25 -0.42 -0.43 0.09 3.52 -24.84 4.54
ROCE(%) 23.09 0.57 0.7 1.05 1.57 -0.38 -0.39 0.11 4.56 -28.17 4.21
Receivable days 0 78.03 163.37 262.32 170.97 758.87 273.37 1502.24 52.5 158.29 78.04
Inventory Days 0 463.94 179.94 187.9 505.48 1604.98 97.66 207.54 52.75 103.98 207.77
Payable days 0 51.54 90.03 157.98 289.28 721.14 62.95 0 111.02 281.73 286.21
PER(x) 0 0 0 0 0 0 0 1029.41 40.44 0 16.82
Price/Book(x) 0 0 0 0 0 0 2.36 0.9 0.84 0.73 0.75
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0 1.34 0.69 1.17 4.21 14.2 6.22 10.42 0.59 1 0.3
EV/Core EBITDA(x) -1.87 127.06 64.68 34.59 24.72 -477.32 -2080.15 227.3 21.44 -2.21 23.37
Net Sales Growth(%) -100 0 110.06 -39.44 -72.29 -69.76 1007.42 -76.03 6045.6 -45.42 541.64
EBIT Growth(%) 405.34 -90.37 111.74 51.56 50.29 -124.37 -3.05 129.27 0 -1020.81 117.18
PAT Growth(%) 359.77 -90.1 37.3 53.88 63 -134.02 -2.01 120.16 0 -1167.55 116.36
EPS Growth(%) 359.77 -90.85 48.5 53.88 63 -134.02 -2.01 120.21 3727.88 -1167.55 116.37
Debt/Equity(x) 0 0 0 0 0 0 0.02 0.01 0.02 0.01 0.58
Current Ratio(x) 7.11 5.32 4.02 6.52 7.34 2.58 18.72 63.32 1.42 1.7 1.07
Quick Ratio(x) 7.11 1.91 2.83 5.04 4.11 1.06 17.01 58.08 0.96 1.6 0.4
Interest Cover(x) 175.35 11.37 137.13 193.75 1152.45 -1657.75 -123 12 113.55 0 48.54
Total Debt/Mcap(x) 0 0 0 0 0 0 0.01 0.01 0.03 0.01 0.79

Vaxfab Enterprise Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 0 0 0 0 0 0 0 0 0 0
FII 0 0 0 0 0 0 0 0.6 0.6 0.13
DII 0 0 0 0 0 0 0 0 0 0
Public 100 100 100 100 100 100 100 99.4 99.4 99.87
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Vaxfab Enterprise News

Vaxfab Enterprise Pros & Cons

Pros

Cons

  • Promoter holding is low: 0%.
  • Company has a low return on equity of -6% over the last 3 years.
  • Debtor days have increased from 281.73 to 286.21days.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!